title: Interview with David S. Fedson, MD, Former Professor of Medicine, University of Virginia School of Medicine, and Director of Medical Affairs, Aventis Pasteur MSD by Madeline Drexler.
authors.forename: David S
authors.initials: DS
authors.lastname: Fedson
mesh_terms: D023482:Bioterrorism / Q000517:prevention & control; D004196:Disease Outbreaks / Q000517:prevention & control*; D004345:Drug Industry / Q000458:organization & administration; D014943:Global Health; D006288:Health Planning Organizations / Q000458:organization & administration; D006801:Humans; D009980:Influenza A virus / Q000472:pathogenicity; D007252:Influenza Vaccines / Q000138:chemical synthesis / Q000191:economics; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control* / Q000821:virology; D032541:Mass Vaccination / Q000941:ethics / Q000458:organization & administration; D009316:National Institutes of Health (U.S.); D011057:Politics; D014481:United States / Q000453:epidemiology
chemical_list: D007252:Influenza Vaccines